Table 2.

Univariate and multivariate Cox regression analysis of neoadjuvant immunotherapy vs. adjuvant immunotherapy

Variable		N (%)	Univariable analysis		Multivariable analysis
			Hazard Ratio (95% CI)	P	Hazard Ratio (95% CI)	P
Immunotherapy	Neoadjuvant immunotherapy	408 (77.57)	1.06 (0.80–1.39)	0.703	1.06 (0.79–1.41)	0.714
	Adjuvant immunotherapy	118 (22.43)	Ref		Ref

The multivariable analysis was adjusted for the age at diagnosis, sex, race, income, education, place of living, treatment facility type, insurance status, comorbidity score, and year of diagnosis